ArticleMolecular therapy. Oncology2025

An attenuated coxsackievirus B5 mutant carrying VP1-N157K retains oncolytic potency against non-small cell lung cancer.

Lifang Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.